MX2019010370A - Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. - Google Patents
Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.Info
- Publication number
- MX2019010370A MX2019010370A MX2019010370A MX2019010370A MX2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A
- Authority
- MX
- Mexico
- Prior art keywords
- purified
- compositions
- cannabinoids
- terpenes
- compositions comprise
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyrane Compounds (AREA)
Abstract
En este documento se divulgan nuevas composiciones que comprenden un cannabinoide purificado y un terpeno purificado. En una realizacion, las composiciones comprenden uno o mas cannabinoides purificados. En una realizacion, las composiciones comprenden uno o mas cannabinoides purificados en combinacion con uno o mas terpenos purificados. En una realizacion, las composiciones comprenden proporciones no naturales. En una realizacion, las composiciones comprenden concentraciones no naturales. En una realizacion, las composiciones comprenden efectos inesperados y/o sinergicos.
Applications Claiming Priority (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465688P | 2017-03-01 | 2017-03-01 | |
US201762469415P | 2017-03-09 | 2017-03-09 | |
US201762475153P | 2017-03-22 | 2017-03-22 | |
US201762477990P | 2017-03-28 | 2017-03-28 | |
US201762489360P | 2017-04-24 | 2017-04-24 | |
US201762490567P | 2017-04-26 | 2017-04-26 | |
US201762490465P | 2017-04-26 | 2017-04-26 | |
US201762491175P | 2017-04-27 | 2017-04-27 | |
US201762491160P | 2017-04-27 | 2017-04-27 | |
US201762491899P | 2017-04-28 | 2017-04-28 | |
US201762491980P | 2017-04-28 | 2017-04-28 | |
US201762509651P | 2017-05-22 | 2017-05-22 | |
US201762510229P | 2017-05-23 | 2017-05-23 | |
US201762510660P | 2017-05-24 | 2017-05-24 | |
US201762510672P | 2017-05-24 | 2017-05-24 | |
US201762511218P | 2017-05-25 | 2017-05-25 | |
US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
PCT/US2018/020440 WO2018160827A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019010370A true MX2019010370A (es) | 2019-10-22 |
Family
ID=63370542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019010370A MX2019010370A (es) | 2017-03-01 | 2018-03-01 | Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3589129A4 (es) |
CN (1) | CN110582206A (es) |
AU (1) | AU2018227544A1 (es) |
BR (1) | BR112019018088A2 (es) |
CA (1) | CA3054690A1 (es) |
CO (1) | CO2019009413A2 (es) |
IL (1) | IL268929A (es) |
MX (1) | MX2019010370A (es) |
PE (1) | PE20200383A1 (es) |
WO (1) | WO2018160827A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019147690A1 (en) | 2018-01-23 | 2019-08-01 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
WO2021012044A1 (en) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
JP2023508257A (ja) * | 2019-11-26 | 2023-03-02 | ライコレッド リミテッド. | カンナビノイドおよびリコピンの抗炎症性の相乗的組み合わせ |
CN115605289A (zh) * | 2020-04-29 | 2023-01-13 | 利加尔有限合伙公司(Nz) | 印迹聚合物及其使用方法 |
EP4188915A1 (en) * | 2020-07-27 | 2023-06-07 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
WO2022165165A1 (en) * | 2021-01-29 | 2022-08-04 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种***素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
WO2023245185A1 (en) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprising cannabinoids and methods of preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物***素次***二酚(cbdv)來治療癲癇之用途 |
ES2784229T3 (es) * | 2013-11-20 | 2020-09-23 | Panag Pharma Inc | Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular |
MX2017010872A (es) * | 2015-02-27 | 2018-05-07 | Ebbu Llc | Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. |
-
2018
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/en unknown
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 CA CA3054690A patent/CA3054690A1/en active Pending
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/en not_active Withdrawn
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018160827A1 (en) | 2018-09-07 |
PE20200383A1 (es) | 2020-02-24 |
BR112019018088A2 (pt) | 2020-03-24 |
EP3589129A1 (en) | 2020-01-08 |
CO2019009413A2 (es) | 2019-09-09 |
AU2018227544A1 (en) | 2019-08-29 |
IL268929A (en) | 2019-10-31 |
CA3054690A1 (en) | 2018-09-07 |
EP3589129A4 (en) | 2020-11-25 |
CN110582206A (zh) | 2019-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019010370A (es) | Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. | |
MX2017010872A (es) | Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. | |
EP3687527A4 (en) | COMPOSITIONS CONSISTING OF CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENES AND FLAVONOIDS AND THEIR USE IN THE TREATMENT OF INSOMNIA | |
JOP20170055B1 (ar) | تركيبة شراب تحتوي على اليولوز وطعام يحتوي على التركيبة | |
WO2017083363A9 (en) | Natural preservatives and antimicrobial agents, including compositions thereof | |
WO2021217004A3 (en) | Methods and compositions for treating virus-associated inflammation | |
EP3758671A4 (en) | NATURAL 1,2-ALKANEDIOLS, COMPOSITIONS WITH NATURAL 1,2-ALKANEDIOLS AND PROCESS FOR THEIR PRODUCTION | |
SG10201808151RA (en) | Cortistatin analogues and syntheses and uses thereof | |
MY185981A (en) | Glycoside compositions | |
CL2008001755A1 (es) | Metodo para reducir efectos de deterioro asociado con pesticidas, fertilizantes o una combinacion de los mismos en una planta que comprende el tratamiento con al menos un compuesto derivado de ciclopropeno. | |
MX2017012803A (es) | Produccion de poliuretanos de bajas emisiones. | |
MX2019010950A (es) | Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso. | |
WO2018127612A3 (en) | Compositions comprising lespedeza plant extract | |
MX2016012559A (es) | Composiciones de protector solar. | |
UY38284A (es) | Composiciones y métodos para agonizar el receptor cb2 | |
GB201901099D0 (en) | Methods, uses and compositions | |
MX2017013278A (es) | Odorante osmanthus. | |
MX2020010424A (es) | Comprimido o composicion que contiene n-acil etanolamina y cannabinoides. | |
CO2017004809A2 (es) | Composiciones de triptamidas | |
IL270833B (en) | Synergistic preparations containing (r)-dimiracetam (1) and (s)-dimidacetam (2) in a non-sequential ratio | |
MX2020001992A (es) | Peliculas acrilicas quebradizas y etiquetas para la prevencion de la falsificacion que comprenden las mismas. | |
MX2019009200A (es) | Composiciones y métodos para inhibir el reticulón 4. | |
MX2019013642A (es) | Compuestos, composiciones y metodos. | |
MX2018007398A (es) | Composicion para mejorar la sensacion bucal. | |
MX2018008376A (es) | Composiciones de fragancia de liberacion prolongada. |